Correlation Between Adimmune Corp and Sinphar Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Adimmune Corp and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adimmune Corp and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adimmune Corp and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Adimmune Corp and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adimmune Corp with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adimmune Corp and Sinphar Pharmaceutical.

Diversification Opportunities for Adimmune Corp and Sinphar Pharmaceutical

0.76

Correlation Coefficient

Adimmune Corp  Sinphar Pharmaceutical

Poor diversification

The 3 months correlation between Adimmune and Sinphar is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Adimmune Corp and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Adimmune Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adimmune Corp are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Adimmune Corp i.e., Adimmune Corp and Sinphar Pharmaceutical go up and down completely randomly.

Pair Corralation between Adimmune Corp and Sinphar Pharmaceutical

Assuming the 90 days trading horizon Adimmune Corp is expected to under-perform the Sinphar Pharmaceutical. In addition to that, Adimmune Corp is 1.75 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.36 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.13 per unit of volatility. If you would invest  3,250  in Sinphar Pharmaceutical Co on September 4, 2024 and sell it today you would lose (165.00) from holding Sinphar Pharmaceutical Co or give up 5.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Adimmune Corp  vs.  Sinphar Pharmaceutical Co

Adimmune Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adimmune Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Sinphar Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Adimmune Corp and Sinphar Pharmaceutical

The main advantage of trading using opposite Adimmune Corp and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adimmune Corp position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.

The idea behind Adimmune Corp and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..